Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2021 - 01 - 04 save search
Mirati Therapeutics To Present At The 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-04 (Crawled : 23:07) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.09%
H: 1.43%
C: -2.58%
j.p. morgan healthcare conference
Prelude Therapeutics Announces Launch of Proposed Public Offering
Published: 2021-01-04 (Crawled : 22:00) - globenewswire.com
PRLD | $3.44 -17.7% -21.51% 110K
|
Health Technology
|
| O: -2.95%
H: 0.29%
C: -8.65%
offering therapeutics publication
Rubius Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-04 (Crawled : 21:03) - globenewswire.com
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: -0.49%
H: 4.28%
C: 2.08%
Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock
Published: 2021-01-04 (Crawled : 21:02) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: -4.1%
H: 6.15%
C: 0.84%
offering
ADC Therapeutics to Participate in SternIR Virtual Corporate Access Event
Published: 2021-01-04 (Crawled : 19:00) - biospace.com/
ADCT | $4.76 -4.03% 0.0% 280K
|
Health Technology
|
| O: 1.37%
H: 0.51%
C: -0.71%
therapeutics
Protagonist Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-04 (Crawled : 19:00) - biospace.com/
PTGX | $25.23 -1.33% -1.35% 390K
|
Health Technology
|
| O: 0.74%
H: 0.94%
C: -3.5%
j.p. morgan healthcare conference
Repare Therapeutics to Present at Virtual Investor Conferences in January
Published: 2021-01-04 (Crawled : 19:00) - biospace.com/
RPTX 4 | $3.025 -5.76% -6.12% 140K
|
Health Technology
|
| O: 3.18%
H: 6.67%
C: 2.43%
conference presentation therapeutics
Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Published: 2021-01-04 (Crawled : 18:00) - globenewswire.com
AGRX | $0.6022 0.0% 3M
|
Health Technology
|
| O: -0.35%
H: 0.35%
C: -2.45%
PTC Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-04 (Crawled : 18:00) - biospace.com/
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: -0.62%
H: 1.17%
C: -0.25%
j.p. morgan healthcare conference
Akebia Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-04 (Crawled : 18:00) - biospace.com/
AKBA | $1.38 -0.72% -0.72% 2.5M
|
Health Technology
|
| O: 1.07%
H: 4.59%
C: 3.36%
j.p. morgan healthcare conference
Poseida Therapeutics to Participate in SternIR Virtual Corporate Access Event
Published: 2021-01-04 (Crawled : 18:00) - biospace.com/
PSTX | News | $2.005 -1.72% -1.75% 520K
|
Health Technology
|
| O: 1.64%
H: 2.06%
C: -1.79%
therapeutics
Inhibikase Therapeutics Announces Partnership with Clintrex Research Corporation; C. Warren Olanow, MD, to Serve as Interim Chief Medical Officer
Published: 2021-01-04 (Crawled : 16:00) - biospace.com/
IKT | News | $2.13 0.19% 28K
|
Health Technology
|
| O: 3.77%
H: 0.0%
C: -2.79%
research partnership
Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the United States
Published: 2021-01-04 (Crawled : 15:00) - biospace.com/
ARCT 4 | $26.31 -4.81% -5.06% 610K
|
Health Technology
|
| O: 0.97%
H: 17.01%
C: 11.64%
vaccine fda phase 2
Harpoon Therapeutics Doses First Patient with HPN328, an Anti-DLL3 T Cell Engager for Treatment of Small Cell Lung Cancer and other DLL3-Associated TumorsHPN328, Harpoon’s fourth TriTAC® T cell engager, enters clinical development
Published: 2021-01-04 (Crawled : 15:00) - biospace.com/
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 3.13%
H: 17.16%
C: 13.54%
lung cancer cancer t-cell
Chinook Therapeutics to Present at Upcoming Investor Conferences
Published: 2021-01-04 (Crawled : 14:00) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: 0.82%
H: 2.56%
C: -0.13%
conference presentation therapeutics
Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
Published: 2021-01-04 (Crawled : 14:00) - globenewswire.com
BLPH | $0.0545 -45.37% 15M
|
Health Technology
|
| O: 2.1%
H: 2.79%
C: 1.91%
bioconnect 2021 conference
Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma’s Acquisition of Arvelle Therapeutics
Published: 2021-01-04 (Crawled : 13:03) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 2.52%
H: 10.7%
C: 9.47%
acquisition gene therapies therapy gene therapy pharma
Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF
Published: 2021-01-04 (Crawled : 13:03) - globenewswire.com
PLRX | $12.23 -4.9% -5.15% 360K
|
Health Technology
|
| O: 1.23%
H: 8.41%
C: 6.61%
Celldex Appoints Freddy A. Jimenez, Esq. as Senior Vice President and General Counsel
Published: 2021-01-04 (Crawled : 13:03) - globenewswire.com
CLDX | $38.49 -2.88% -2.96% 580K
|
Health Technology
|
| O: 2.51%
H: 6.85%
C: 6.35%
F-star Therapeutics Announces First Patient Dosed in FS222 Phase 1 Clinical Trial
Published: 2021-01-04 (Crawled : 13:01) - globenewswire.com
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 2.94%
H: 2.36%
C: -9.45%
trial phase 3 phase 1 phase 2
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.